Wang Jessie, Chun Lindsay Y, Qiu Mary
Department of Ophthalmology & Visual Science, University of Chicago, Chicago, IL, USA.
Case Rep Ophthalmol Med. 2023 Oct 26;2023:5719002. doi: 10.1155/2023/5719002. eCollection 2023.
To describe a single surgeon's experience utilizing prompt primary slow-burn transscleral cyclophotocoagulation (CPC) with prior or concurrent anti-VEGF and subsequent aqueous shunt as needed in NVG eyes with near-total synechial angle closure at presentation.
Retrospective chart review of all NVG patients with uncontrolled IOP, active anterior segment NV, near-total synechial angle closure, and no contraindications to prompt anti-VEGF who received CPC within 3 days of presentation with at least 6 months of follow-up.
Eight patients with mean age 60.6 years were included. Underlying etiologies were CRVO ( = 3), PDR ( = 2), CRAO ( = 1), BRVO ( = 1), and chronic RD ( = 1). All eyes underwent CPC with intravitreal anti-VEGF within 3 days of presentation. Five patients did not require subsequent aqueous shunts through a mean follow-up of 15 months; most recent visual acuities ranged from 20/40 to LP, and IOPs ranged from 5 to 11 mmHg on 0 to 3 IOP-lowering medications. Three patients who required subsequent tubes had complete regression of active anterior segment NV at the time of surgery. Most recent visual acuities ranged from 20/100 to 20/125, and IOPs ranged from 8 to 14 mmHg on 0 meds at a mean follow-up of 10 months. No eyes developed uncontrolled inflammation, sympathetic ophthalmia, or phthisis.
Prompt primary slow-burn CPC with prior or concurrent anti-VEGF may be an effective strategy to immediately lower IOP in acute NVG eyes with active anterior segment NV and near-total synechial angle closure. If IOP becomes uncontrolled later, an aqueous shunt can be implanted in a controlled setting after active anterior segment NV has regressed.
描述一位外科医生在初诊时近全虹膜粘连性房角关闭的新生血管性青光眼(NVG)眼中,先行或同时应用抗血管内皮生长因子(anti-VEGF),并根据需要随后进行房水引流,采用即时原发性缓慢烧灼性经巩膜睫状体光凝术(CPC)的经验。
对所有初诊时眼压控制不佳、眼前段新生血管活跃、近全虹膜粘连性房角关闭且无即时抗VEGF治疗禁忌证,并在就诊3天内接受CPC且随访至少6个月的NVG患者进行回顾性病历审查。
纳入8例平均年龄60.6岁的患者。潜在病因包括视网膜中央静脉阻塞(CRVO,3例)、增殖性糖尿病视网膜病变(PDR,2例)、视网膜中央动脉阻塞(CRAO,1例)、视网膜分支静脉阻塞(BRVO,1例)和慢性视网膜脱离(1例)。所有患眼在就诊3天内均接受了CPC联合玻璃体内抗VEGF治疗。5例患者在平均15个月的随访期间无需随后进行房水引流;最新视力范围为20/40至光感(LP),眼压在使用0至3种降眼压药物时为5至11 mmHg。3例需要随后植入引流管的患者在手术时眼前段新生血管完全消退。最新视力范围为20/100至20/125,平均随访10个月时眼压在未使用药物的情况下为8至14 mmHg。没有患眼出现眼压控制不佳的炎症、交感性眼炎或眼球痨。
先行或同时应用抗VEGF的即时原发性缓慢烧灼性CPC可能是一种有效的策略,可立即降低伴有眼前段新生血管活跃和近全虹膜粘连性房角关闭的急性NVG患眼的眼压。如果后期眼压控制不佳,可在眼前段新生血管消退后在可控条件下植入房水引流装置。